Parametric multistate survival models: Flexible modelling allowing transition-specific distributions with application to estimating clinically useful measures of effect differences

Stat Med. 2017 Dec 20;36(29):4719-4742. doi: 10.1002/sim.7448. Epub 2017 Sep 5.

Abstract

Multistate models are increasingly being used to model complex disease profiles. By modelling transitions between disease states, accounting for competing events at each transition, we can gain a much richer understanding of patient trajectories and how risk factors impact over the entire disease pathway. In this article, we concentrate on parametric multistate models, both Markov and semi-Markov, and develop a flexible framework where each transition can be specified by a variety of parametric models including exponential, Weibull, Gompertz, Royston-Parmar proportional hazards models or log-logistic, log-normal, generalised gamma accelerated failure time models, possibly sharing parameters across transitions. We also extend the framework to allow time-dependent effects. We then use an efficient and generalisable simulation method to calculate transition probabilities from any fitted multistate model, and show how it facilitates the simple calculation of clinically useful measures, such as expected length of stay in each state, and differences and ratios of proportion within each state as a function of time, for specific covariate patterns. We illustrate our methods using a dataset of patients with primary breast cancer. User-friendly Stata software is provided.

Keywords: competing risks; multistate models; prediction; survival analysis; time-dependent effects.

MeSH terms

  • Breast Neoplasms / mortality
  • Breast Neoplasms / surgery
  • Computer Simulation
  • Female
  • Humans
  • Length of Stay
  • Markov Chains*
  • Models, Statistical
  • Proportional Hazards Models
  • Risk Assessment / methods*
  • Risk Factors
  • Survival Analysis*
  • Time Factors